Difference in cell proliferation between two structurally different lesions in colorectal adenomas: High-grade dysplasia and carcinoma in situ

Anticancer Research

Volumn 27, Issue 6 C, 2007, Pages 4321-4324

  Rubio, C A ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Carcinoma in situ; DNA; Dysplasia; RNA

Indexed keywords

EOSIN; HEMATOXYLIN; MONOCLONAL ANTIBODY KI 67;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CARCINOMA IN SITU; CELL PROLIFERATION; CHROMATIN; CLINICAL ARTICLE; COLORECTAL ADENOMA; CONTROLLED STUDY; DYSPLASIA; FEMALE; HUMAN; HUMAN TISSUE; MALE; NUCLEOLUS; PRIORITY JOURNAL; PROTEIN EXPRESSION; STAINING;

ADENOMA; AGED; CARCINOMA IN SITU; CELL PROLIFERATION; COLORECTAL NEOPLASMS; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; KI-67 ANTIGEN; MALE; MIDDLE AGED; PRECANCEROUS CONDITIONS;

EID: 37549040154     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Ackermann S, Gehrsitz C, Mehlhorn G and Beckmann MW: Management and course of histologically verified cervical carcinoma in situ during pregnancy. Acta Obstet Gynecol Scand 85: 1134-1137, 2006.
2. Daly MB: Tamoxifen in ductal carcinoma in situ. Semin Oncol 33: 647-639, 2006.
3. Ondo AL, Mings SM, Pestak RM and Shanler SD: Topical combination therapy for cutaneous squamous cell carcinoma in situ with 5-fluorouracil cream and imiquimod cream in patients who have failed topical monotherapy. J Am Acad Dermatol 55: 1092-1094, 2006.
4. Raju RR, Goldblum JR and Hart WR: Pagetoid squamous cell carcinoma in situ (pagetoid Bowen's disease) of the external genitalia. Int J Gynecol Pathol 22: 127-135, 2003.
5. Wilkin TJ, Palmer S, Brudney KF, Chiasson MA and Wright TC: Anal intraepithelial neoplasia in heterosexual and homosexual HIV-positive men with access to antiretroviral therapy. J Infect Dis 190: 1685-1691, 2004.
6. Brehm R, Ruttinger C, Fischer P, Gashaw I, Winterhager E, Kliesch S, Bohle RM, Steger K and Bergmann M: Transition from preinvasive carcinoma in situ to seminoma is accompanied by a reduction of connexin 43 expression in Sertoli cells and germ cells. Neoplasia 8: 499-450, 2006.
7. Komenaka IK, Mir R, de Graft-Johnson JB and Wise L: Severe high-grade dysplasia and in situ carcinoma of the common bile duct and pancreatic duct. Lancet Oncol 4: 373-375, 2003.
8. Snijders PJ, Breuer RH, Sutedja TG, Egging M, Voorhorst FJ, Steenbergen RD, van der Linden HC, Risse EK, Berkhof J, de Vries EG, van der Zee AG, Postmus PE, Meijer CJ and Smit EF: Elevated hTERT mRNA levels: A potential determinant of bronchial squamous cell carcinoma (in situ). Int J Cancer 109: 412-417, 2004.
9. Costa DB, Chen AA, Marginean EC and Inzucchi SE: Diabetes mellitus as the presenting feature of extrahepatic cholangiocarcinoma in situ: case report and review of literature. Endocr Pract 10: 417-423, 2004.
10. Albores-Saavedra J, Shukla D, Carrick K and Henson DE: In situ and invasive adenocarcinomas of the gallbladder extending into or arising from Rokitansky-Aschoff sinuses: a clinicopathologic study of 49 cases. Am J Surg Pathol 28: 621-628, 2004.
11. Yin H, He Q, Li T and Leong AS: Cytokeratin 20 and Ki-67 to distinguish carcinoma in situ from flat non-neoplastic urothelium. Appl Immunohistochem Mol Morphol 14: 260-265, 2006.
12. Morson BC, Whiteway JE, Jones EA, Macrae FA and Williams CB: Histopathology and prognosis of malignant colorectal polyps treated by endoscopic polypectomy. Gut 25: 437-444, 1984.
13. Loeve F, Boer R, Zauber AG, Van Ballegooijen M, Van Oortmarssen GJ, Winawer SJ and Habbema JD: National Polyp Study data: evidence for regression of adenomas. Int J Cancer 111: 633-639, 2004.
14. Schlemper R J, Riddell, Kato Y, Borchard F, Cooper HS, Rubio CA, Rugge M, Shimuzu M, Watanabe H and Yamabe H: International concensus on the classification of gastrointestinal epithelial neoplasia. The Vienna classification. Gut 47: 251-255, 2000.
15. Rubio CA, Nesi G, Messerini L, K Mandai, M Itabashi and K Takubo: The Vienna classification applied to colorectal adenomas. J Hepatol Gastroenterol 21: 1697-1703, 2006.
16. Rubio CA and Porwit-McDonald A: A method to quantitate the relative nuclear area of colorectal polyps by image analysis. Anal Quant Cytol Histol 13: 155-158, 1991.
17. Rubio CA: Qualitative DNA differences between two structurally different lesions: high-grade dysplasia and carcinoma in situ in colorectal adenomas Anticancer Res 27: 2881-2886, 2007.
18. Moldovan GL, Pfander B and Jentsch S: PCNA, the maestro of the replication fork. Cell 129: 665-679, 2007.
19. Alberts B: Cells and genomes. In: Molecular Biology of the Cell. Alberts B, Johnson A, Lewis J, Raff M, Roberts K, Walters P (eds.). Garland Science, Taylor and Francis Group, 4th ed., pp. 3-35, 2002.
20. Zaidi SK, Young DW, Javed A, Pratap J, Montecino M, van Wijnen A, Lian JB, Stein JI and Stein GS: Nuclear microenvironments in biological control and cancer. Nat Rev Cancer 7: 454-463, 2007.
21. Bignold LP: Variation, "evolution", immortality and genetic instabilities in tumour cells. Cancer Lett 253: 155-169, 2007.
22. Kelland LR: Overcoming the immortality of tumour cells by telomere and telomerase based cancer therapeutics - current status and future prospects. Eur J Cancer 41: 971-979, 2005.
23. Rubio CA: Further studies on the arrest of cell proliferation in tumour cells at the invading front of colonic adenocarcinomas. J Gastroenter Hepat, 2007 (in press).
24. Vogelstein B, Fearon ER, Hamilton SR, Kern SE, Preisinger AC, Leppert M, Nakamura Y, White R, Smits AM and Bos JL: Genetic alterations during colorectal-tumor development. N Engl J Med 319: 525-532, 1988.